Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of mice
- 318 Downloads
The purpose of this study was to investigate the effect of zoledronate (ZA) on osteoclast functions and viability in the tibiae of 8-week-old male mice. After weekly intravenous administration of ZA (125 μg/kg body weight) for 8 weeks, the mice were fixed by transcardial perfusion of 4 % paraformaldehyde under anesthesia, and their tibiae were extracted for histochemical analysis. Compared with the control group, many tartrate-resistant acidic phosphatase-positive osteoclasts were found on the surface of the trabecular bone, but cartilage cores were obviously increased in the metaphysis of the ZA group. Osteoclasts of both groups showed similar expression of cathepsin K and matrix metalloproteinase-9. However, hardly any expression of c-src, a gene necessary for ruffled border formation and bone resorption, was found in osteoclasts of the ZA group. Moreover, no expression of CD44 or osteopontin (OPN) was observed in osteoclasts of the ZA group. Taken together, our findings suggest that ZA administration decreases the bone resorption ability of osteoclasts by inhibiting c-src expression and suppressing osteoclast adhesion by interfering with CD44/OPN binding.
KeywordsZoledronate Osteoblasts Osteoclasts C-src Adhesion
This study was partially supported by the National Nature Science Foundation of China (Grant Nos. 81271965; 81470719; 81311140173) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120131110073) to Li M.
The animals were maintained and all experimental procedures were approved by the Committee on the Ethics of Animal Experiments of Shandong University. All surgery was performed under chloral hydrate anesthesia, and all efforts were made to minimize suffering.
Conflict of interest
The authors declare that they have no conflict of interest.
- Dedes PG, Gialeli Ch, Tsonis AI, Kanakis I, Theocharis AD, Kletsas D, Tzanakakis GN, Karamanos NK (2012) Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by thebisphosphonate zoledronic acid. Biochim Biophys Acta 1820:1926–1939PubMedCrossRefGoogle Scholar
- Delaisse JM, Engsig MT, Everts V, del Carmen OM, Ferreras M, Lund L, Vu TH, Werb Z, Winding B, Lochter A, Karsdal MA, Troen T, Kirkeqaard T, Lenhard T, Heegaard AM, Neff L, Baron R, Foged NT (2000) Proteinases in bone resorption: obvious and less obvious roles. Clin Chim Acta 291:223–234PubMedCrossRefGoogle Scholar
- Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ (2001) Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296:235–242PubMedGoogle Scholar
- Li M, Amizuka N, Takeuchi K, Freitas PH, Kawano Y, Hoshino M, Oda K, Nozawa-Inoue K, Maeda T (2006) Histochemical evidence of osteoclastic degradation of extracellular matrx in osteolytic metastasis originating from human lung small carcinoma (SBC-5) cells. Microsc Res Tech 69:73–83PubMedCrossRefGoogle Scholar
- Oda K, Amaya Y, Fukushi-Irie M, Kinameri Y, Ohsuye K, Kubota I, Fujimura S, Kobayashi J (1999) A general method for rapid purification of soluble versions of glycosyphosphatidylinositol-anchored proteins expressed in insect cells: an application for human tissue-nonspecific alkaline phosphatase. J Biochem 126:694–699PubMedCrossRefGoogle Scholar
- Vora SR (2013) CD44−/− animals display decreased orthodontic tooth movement using a murine model. UMI Dissertations Publishing 1547599Google Scholar